NCI BSA approves nine new and reissued concepts

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The NCI Board of Scientific Advisors approved nine new and reissued concepts at a meeting held March 28-29.

Also at the meeting, NCI Director Ned Sharpless—who recently announced that he would step down April 29—discussed the state of FY22 funding and President Joe Biden’s reinvigorated Moonshot (The Cancer Letter, Apr. 1, Apr. 4, 2022). 

Douglas Lowy, principal deputy director of NCI, delivered a presentation on how the FY22 NCI budget will affect research project grant paylines (The Cancer Letter, Apr. 1, 2022). Paylines for R01 grants for new and established investigators will stay at the 11th percentile, complicating NCI’s goal of reaching the 15th percentile by 2025. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Alice Tracey
Alice Tracey
Reporter
Table of Contents

YOU MAY BE INTERESTED IN

Acting Director Dr. Krzysztof Ptak’s words reverberated throughout the meeting room—and the heads of several of us—during the National Cancer Institute’s Office of Cancer Centers update on the final day of the 2024 Association of American Cancer Institutes/Cancer Center Administrators Forum Annual Meeting in Chicago.
Virginia Commonwealth University has been awarded a five-year, $9 million grant from NCI to establish a pioneering Cancer Control Equity Research Center. This initiative aims to enhance the dissemination and implementation of health promotion and cancer prevention services for individuals and families residing in Virginia’s Housing and Urban Development-administered income-based housing communities in the Greater Richmond region and Hampton Roads.
Alice Tracey
Alice Tracey
Reporter

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login